We have a pretty low likelihood of significant bad news in the next two years. Our big hurdle in the near term is funding for Phase IIB. I'd give us a 99% chance of getting the Phase IIB funded. Will it be funded in a way that is favorable to shareholders? Who knows, but I think the chances of us not being funded at all and having to drop the program is basically nil.
I think the only things that could have us see a similar precipitous decline in share price are either safety problems in the Phase IIB (unlikely given our past safety profile), or weak efficacy results that show little/nothing in the way of clinically meaningful or statistically significant results over placebo (low-moderate likelihood).
So basically we will have to wait 2-2.5 years for efficacy results in a placebo-controlled trial, at which point we will either be a billion dollar company or worthless company. But there is little/nothing in the near-term barring unlikely safety problems that would see us tank like ATX.
- Forums
- ASX - By Stock
- Ann: Pause in Trading
We have a pretty low likelihood of significant bad news in the...
-
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.7¢ |
Change
0.003(3.57%) |
Mkt cap ! $78.43M |
Open | High | Low | Value | Volume |
8.4¢ | 8.7¢ | 8.4¢ | $72.99K | 855.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 452608 | 8.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 398595 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 452608 | 0.084 |
3 | 212500 | 0.083 |
2 | 106250 | 0.080 |
2 | 125578 | 0.079 |
2 | 30620 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 398595 | 1 |
0.088 | 400000 | 1 |
0.089 | 135000 | 2 |
0.090 | 794374 | 5 |
0.092 | 50000 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online